Correlation Between SAB Biotherapeutics and ProMIS Neurosciences
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and ProMIS Neurosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and ProMIS Neurosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and ProMIS Neurosciences, you can compare the effects of market volatilities on SAB Biotherapeutics and ProMIS Neurosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of ProMIS Neurosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and ProMIS Neurosciences.
Diversification Opportunities for SAB Biotherapeutics and ProMIS Neurosciences
-0.69 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between SAB and ProMIS is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and ProMIS Neurosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProMIS Neurosciences and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with ProMIS Neurosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProMIS Neurosciences has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and ProMIS Neurosciences go up and down completely randomly.
Pair Corralation between SAB Biotherapeutics and ProMIS Neurosciences
Assuming the 90 days horizon SAB Biotherapeutics is expected to generate 5.27 times more return on investment than ProMIS Neurosciences. However, SAB Biotherapeutics is 5.27 times more volatile than ProMIS Neurosciences. It trades about 0.15 of its potential returns per unit of risk. ProMIS Neurosciences is currently generating about -0.29 per unit of risk. If you would invest 5.26 in SAB Biotherapeutics on September 1, 2024 and sell it today you would earn a total of 1.49 from holding SAB Biotherapeutics or generate 28.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 90.48% |
| Values | Daily Returns |
SAB Biotherapeutics vs. ProMIS Neurosciences
Performance |
| Timeline |
| SAB Biotherapeutics |
| ProMIS Neurosciences |
SAB Biotherapeutics and ProMIS Neurosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with SAB Biotherapeutics and ProMIS Neurosciences
The main advantage of trading using opposite SAB Biotherapeutics and ProMIS Neurosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, ProMIS Neurosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProMIS Neurosciences will offset losses from the drop in ProMIS Neurosciences' long position.| SAB Biotherapeutics vs. SAB Biotherapeutics | SAB Biotherapeutics vs. Jasper Therapeutics | SAB Biotherapeutics vs. NRx Pharmaceuticals |
| ProMIS Neurosciences vs. Tff Pharmaceuticals | ProMIS Neurosciences vs. Eliem Therapeutics | ProMIS Neurosciences vs. Inhibrx | ProMIS Neurosciences vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |